JENSEN; Thomas Kirkegaard
Patent Applications and Registrations
Patent applications and USPTO patent grants for JENSEN; Thomas Kirkegaard.The latest application filed is for "use of arimoclomol in the treatment of niemann pick disease".
- JENSEN; Thomas Kirkegaard - Rodovre DK
- Jensen; Thomas Kirkegaard - Frederiksberg C DK
- Jensen; Thomas Kirkegaard - Fredericksberg C DK
| Patent | Date |
|---|---|
| Use Of Arimoclomol In The Treatment Of Niemann Pick Disease App 20220211687 - JENSEN; Thomas Kirkegaard ; et al. | 2022-07-07 |
| Arimoclomol For Treating Glucocerebrosidase Associated Disorders App 20220133707 - HINSBY; Anders Morkeberg ; et al. | 2022-05-05 |
| Use of HSP70 as a regulator of enzymatic activity Grant 11,304,941 - Jensen , et al. April 19, 2 | 2022-04-19 |
| Arimoclomol for treating glucocerebrosidase associated disorders Grant 11,253,505 - Hinsby , et al. February 22, 2 | 2022-02-22 |
| Arimoclomol formulation Grant 11,229,633 - Hinsby , et al. January 25, 2 | 2022-01-25 |
| Use of Hsp70 as a regulator of enzymatic activity Grant 11,045,460 - Jensen , et al. June 29, 2 | 2021-06-29 |
| Heat Shock Proteins And Cholesterol Homeostasis App 20210186949 - JENSEN; Thomas Kirkegaard ; et al. | 2021-06-24 |
| Hsp70 Protein Levels In Pbmc Samples As Biomarker For Disease App 20210164997 - INGEMANN; Linda ; et al. | 2021-06-03 |
| Heat shock proteins and cholesterol homeostasis Grant 10,898,476 - Jensen , et al. January 26, 2 | 2021-01-26 |
| Arimoclomol For Treating Glucocerebrosidase Associated Disorders App 20200289497 - Hinsby; Anders Morkeberg ; et al. | 2020-09-17 |
| Arimoclomol Formulation App 20200261437 - Hinsby; Anders Morkeberg ; et al. | 2020-08-20 |
| Arimoclomol formulation Grant 10,709,700 - Hinsby , et al. | 2020-07-14 |
| Methods For Increasing Intracellular Activity Of Hsp70 App 20200188492 - Jensen; Thomas Kirkegaard ; et al. | 2020-06-18 |
| Use Of Hsp70 As A Regulator Of Enzymatic Activity App 20200121668 - Jensen; Thomas Kirkegaard ; et al. | 2020-04-23 |
| Use Of Hsp70 As A Regulator Of Enzymatic Activity App 20200113888 - Jensen; Thomas Kirkegaard ; et al. | 2020-04-16 |
| Heat Shock Protein Inducers And Frontotemporal Disorders App 20200085812 - Jensen; Thomas Kirkegaard ; et al. | 2020-03-19 |
| Heat Shock Proteins And Cholesterol Homeostasis App 20190201389 - Jensen; Thomas Kirkegaard ; et al. | 2019-07-04 |
| Arimoclomol For Treating Glucocerebrosidase Associated Disorders App 20190111041 - Hinsby; Anders Morkeberg ; et al. | 2019-04-18 |
| Use Of Hsp70 As A Regulator Of Enzymatic Activity App 20180185349 - Jensen; Thomas Kirkegaard ; et al. | 2018-07-05 |
| Use of Hsp70 as a regulator of enzymatic activity Grant 9,884,058 - Jensen , et al. February 6, 2 | 2018-02-06 |
| Arimoclomol Formulation App 20170239232 - Hinsby; Anders Morkeberg ; et al. | 2017-08-24 |
| Methods for increasing intracellular activity of Hsp70 Grant 9,662,375 - Jensen , et al. May 30, 2 | 2017-05-30 |
| Use Of Hsp70 As A Regulator Of Enzymatic Activity App 20160263096 - Jensen; Thomas Kirkegaard ; et al. | 2016-09-15 |
| Use of HSP70 as a regulator of enzymatic activity Grant 9,289,472 - Jensen , et al. March 22, 2 | 2016-03-22 |
| Use Of Hsp70 As A Regulator Of Enzymatic Activity App 20150004151 - Jensen; Thomas Kirkegaard ; et al. | 2015-01-01 |
| Use Of Hsp70 As A Regulator Of Enzymatic Activity App 20140050714 - Jensen; Thomas Kirkegaard ; et al. | 2014-02-20 |
| Use of Hsp70 as a regulator of enzymatic activity Grant 8,540,985 - Jensen , et al. September 24, 2 | 2013-09-24 |
| Methods For Increasing Intracellular Activity Of Hsp70 App 20130230506 - Jensen; Thomas Kirkegaard ; et al. | 2013-09-05 |
| Use Of Hsp70 As A Regulator Of Enzymatic Activity App 20110286993 - Jensen; Thomas Kirkegaard ; et al. | 2011-11-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 